Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

150.57 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, May 26, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 85
Open 150.57
Bid (Size) 150.48 (1)
Ask (Size) 151.08 (1)
Prev. Close 150.57
Today's Range 150.57 - 150.57
52wk Range 105.56 - 175.91
Shares Outstanding N/A
Dividend Yield 3.45%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Overvaluation Is An Obvious Mistake That Can And Should Be Avoided
Massive overvaluation is vulnerable to even the hint of bad news. Almost any negative catalyst can cause havoc to the stock price. 
Via Talk Markets
7 High-Yield Retirement Stocks to Buy for Your Nest Egg
These 7 high-yield retirement stocks to buy are among a list of companies that are dividend aristocrats and offer great dividends. 
Via InvestorPlace

Performance

YTD
+11.19%
+11.19%
1 Month
-3.59%
-3.59%
3 Month
+3.65%
+3.65%
6 Month
+29.23%
+29.23%
1 Year
+31.27%
+31.27%

More News

Read More
7 Ideal Dividend Stocks to Buy for a Rich Retirement
Via InvestorPlace
Teva, Allergan Settle Opioid Lawsuit With West Virginia
Via Benzinga
7 Retirement Stocks to Buy to Turbocharge Your Savings
Via InvestorPlace
What 8 Analyst Ratings Have To Say About AbbVie
Via Benzinga
EMA's CHMP Recommends AbbVie's Upadacitinib For Ulcerative Colitis
Via Benzinga
AbbVie Submits FDA Application For Continuous, 24-Hour Infusion Therapy For Parkinson's
Via Benzinga
CLASS ACTION NOTICE: Kessler Topaz Meltzer & Check, LLP Reminds Investors that a Securities Fraud Class Action Lawsuit Has Been Filed Against AbbVie, Inc.
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
The Daily Biotech Pulse: INmune Bio's Planned Alzheimer's Trial On FDA Hold, Caladrius Stops Enrollment In Heart Disease Study, BiomX Restructures
Via Benzinga
Pfizer's Nearly $7 Billion Acquisition Of Arena Pharma Just Paid Off In A Big Way
Via Investor's Business Daily
AbbVie, Cugene Ink Licensing Pact For Autoimmune & Inflammatory Disease Candidate
Via Benzinga
Global Psychedelics Market Is Expected To Reach $8 Billion By 2029
Via FinancialNewsMedia
If You Invested $1000 In AbbVie 5 Years Ago, Here's How Much You Would Have Today
Via Benzinga
CNBC's Final Trades: AbbVie, Costco Wholesale, Deere And This Kevin O'Leary Pick
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022
Via Benzinga
The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More
Via Benzinga
7 Quality Dividend Stocks to Buy on the Dip
Via InvestorPlace
7 Retirement Stocks to Buy for Any Market Conditions
Via InvestorPlace
9 Stocks Moved By Traders On 'Fast Money: Halftime Report'
Via Benzinga
AbbVie Whale Trades Spotted
Via Benzinga
6 Stocks to Buy to Hedge Your Portfolio in a Down Market
Via InvestorPlace
7 Best Value Stocks to Buy if You Need Some Market Stability in Your Life
Via InvestorPlace
Why Orphan Drug Designation Offers Several Benefits
Via FinancialNewsMedia
Exposures Product Safety
Warren Buffett Stocks: Berkshire Hathaway Goes On Offense In Stock Market, Adds More Apple
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.